59572-415 : Revlimid 15 mg Oral Capsule


NDC59572-415
Labeler: Celgene Corporation
Product Type: Human Prescription Drug
Drug Name:  Revlimid
Dosage Form: Oral Capsule
Application #: NDA021880
Rev. Date: 


Appearance:


Markings: REV;15;mg
Shapes:  Capsule
Colors:  Blue / White
Size (mm): 22
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 59572-415-00: 100 CAPSULE IN 1 BOTTLE (59572‑415‑00)
  • 59572-415-21: 21 CAPSULE IN 1 BOTTLE (59572‑415‑21)

Active Ingredients:

  • Lenalidomide

Dosage Strength:

  • 15 mg

Inactive Ingredients:

  • Anhydrous Lactose
  • Cellulose, Microcrystalline
  • Croscarmellose Sodium
  • Magnesium Stearate

Pharmaceutical Classes:

  • Thalidomide Analog [EPC]

Related Products:

Based on records with the same trade name.
  • 59572-402 Revlimid 2.5 mg Oral Capsule by Celgene Corporation
  • 59572-405 Revlimid 5 mg Oral Capsule by Celgene Corporation
  • 59572-410 Revlimid 10 mg Oral Capsule by Celgene Corporation
  • 59572-420 Revlimid 20 mg Oral Capsule by Celgene Corporation
  • 59572-425 Revlimid 25 mg Oral Capsule by Celgene Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 59572-415 QR Code

< Prev: 59572-410Next: 59572-420 >

Related Discussions:

Revlimid cancer treatment
Looking for facts, side effects, chemical info. ## REVLIMID is a prescription medicine, used to treat adults with: ̶... 1 reply
How Long Does Revlimid Stay In Your System
Just wanted to know how long before this drug is completely out of my husband's system? ## Revlimid contains the act... 14 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.